Confidence Intervals for Validation of Analytical Procedures Under <scp>ICH Q2</scp> ( <scp>R2</scp> )

The International Conference on Harmonisation (ICH) adopted revision 2 (R2) of its Quality Guidance Q2 Validation of Analytical Procedures in 2023. The revision includes a new statement that confidence interval limits for validation performance characteristics (i.e., accuracy and precision) should be compatible with acceptance criteria, unless otherwise justified. It also allows for sponsors to use prior knowledge (e.g., from development or previous studies) to support the validation study conclusion. These two new aspects of ICH Q2(R2) present both opportunities and challenges for the validation of analytical procedures. In this paper, we provide comprehensive examples of how to compute confidence intervals for key validation performance characteristics under different modeling approaches. We also describe methodologies for combining prior knowledge with the validation study results, both from frequentist and Bayesian perspectives. The paper is written in tutorial style and is aimed at statisticians and analytical scientists responsible for validating analytical procedures in compliance with ICH Q2(R2).

Authors

Institutions

Publication Details

Journal
Pharmaceutical Statistics
Published
2025-11-26
DOI
https://doi.org/10.1002/pst.70055
Primary Topic
Pesticide Residue Analysis and Safety
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )

Adam P. Rauk, Chad N. Wolfe, Paul Faya
Pharmaceutical Statistics
Pesticide Residue Analysis and Safety
article

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )

Adam P. Rauk, Chad N. Wolfe, Paul Faya
article en

Abstract

The International Conference on Harmonisation (ICH) adopted revision 2 (R2) of its Quality Guidance Q2 Validation of Analytical Procedures in 2023. The revision includes a new statement that confidence interval limits for validation performance characteristics (i.e., accuracy and precision) should be compatible with acceptance criteria, unless otherwise justified. It also allows for sponsors to use prior knowledge (e.g., from development or previous studies) to support the validation study conclusion. These two new aspects of ICH Q2(R2) present both opportunities and challenges for the validation of analytical procedures. In this paper, we provide comprehensive examples of how to compute confidence intervals for key validation performance characteristics under different modeling approaches. We also describe methodologies for combining prior knowledge with the validation study results, both from frequentist and Bayesian perspectives. The paper is written in tutorial style and is aimed at statisticians and analytical scientists responsible for validating analytical procedures in compliance with ICH Q2(R2).

Pharmaceutical StatisticsVol. 25(1)
Eli Lilly (United States) (US)
Openalex Percentile: Top 58%
Pesticide Residue Analysis and Safety
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.